Sign up USA
Proactive Investors - Run By Investors For Investors

VolitionRx chief hails "wonderful" progress accomplished in 2016

Cameron Reynolds, chief executive at blood-based diagnostic tests company VolitionRx (NYSEMKT:VNRX), discusses the group's full-year results with Proactive Investors.

 
Meet Stratex International plc, W Resources PLC, Wishbone Gold PLC, Condor Gold PLC and Kibo Mining PLC at our event, London, 29 June 2017. Register here »
View full VNRX profile View Profile

VolitionRx Timeline

Big Picture
May 11 2017
Newswire
April 11 2017
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use